| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.088 | 0.8 |